Monday, October 08, 2018
High-Precision Proton Therapy More Effective in Treating Certain Cancers When Combined with Thermal Therapy
The Maryland Proton Treatment Center (MPTC) is now offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these therapies are typically given within an hour of each other.
Thursday, September 27, 2018
University of Maryland School of Medicine Scientist Receives Prestigious Microbiome Award
Owen White, PhD, professor of epidemiology and public health, and Associate Director for Informatics at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM), has received the 2018 Microbiome Pioneer Award. The prestigious honor is part of the Bioinformatics for the Microbiome Symposium organized by Stanford University. The microbiome is the name given collectively to the community of trillions of microbial organisms that live on and within our bodies.
Monday, September 24, 2018
University of Maryland School of Medicine Researchers to Present Original Research at Key Radiation Conference
The University of Maryland School of Medicine (UMSOM) announced that the Division of Translational Radiation Science (DTRS) will participate in the annual meeting of the Radiation Research Society (RRS) on September 23-26, 2018, in Chicago.
Wednesday, September 19, 2018
Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.
Friday, September 14, 2018
Nationwide Research on African-American Kidneys Hopes to Unravel Genetic Variation That Increases Disease Risk
With African-Americans developing kidney failure at rates four to five times higher than Americans of European descent, a groundbreaking nationwide study will track nearly every African-American donor kidney over the next five years.
Wednesday, September 12, 2018
UMSOM Influenza Expert Talks about Risk of Pandemics in Globally Connected World
Wilbur Chen, MD, Associate Professor of Medicine and a vaccine development specialist at the University of Maryland School of Medicine, discussed on WYPR’s “On the Record” how influenza and other diseases can now more easily spread around the world. In an interview with Radio Show Host Sheila Kast, Dr. Chen discussed how the Spanish influenza pandemic in 1918, which led to deaths between 50 and 100 million, actually spread at a slower pace than diseases today.
Tuesday, September 11, 2018
New Study Finds Unexpected Link Between Immune Cells and Male/Female Differences
Researchers at the University of Maryland School of Medicine (UMSOM) have made a surprising discovery: during fetal development, a particular immune cell seems to play a key role in determining the male or female characteristics of the brain.
Thursday, September 06, 2018
University of Maryland Cardiomyopathy Program Named National Center of Excellence
The Hypertrophic Cardiomyopathy Program at the University of Maryland Heart & Vascular Center (UMHVC) has been recognized as a Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA) – one of about 30 Centers of Excellence nationwide and the only HCMA-recognized center in Maryland. The UMHVC is part of the University of Maryland Medical Center (UMMC) and the University of Maryland School of Medicine (UMSOM).
Tuesday, September 04, 2018
Maryland Proton Treatment Center Eyes Future, Strengthens Capital Structure with $277.4 Million Bond Deal
The Maryland Proton Treatment Center (MPTC) announced today that it has taken a major step in strengthening its balance sheet and capital structure to better position it to treat a growing number of cancer patients with its state-of-the-art therapy.
Tuesday, August 21, 2018
New Wave of Complex Street Drugs Puzzles Emergency Doctors
Study May Fuel Need for More Comprehensive Drug Testing in Hospitals